Inventor · disambiguated record
Ying Luo
Also filed as: LUO YING · LUO YING-CHIN
36 granted patents·11 pending applications·316 citations·filing 1997–2023
97Inventor score
Files withRIGEL PHARMACEUTICALS INC27K H S MUSICAL INSTR CO LTD3SERVIER LAB3BEIJING CONTINENT PHARMACEUTICALS CO LTD2LUO YING2
Top patents by PatentIndex Score
47 records- 0186US5989872AMethods and compositions for transferring DNA sequence information among vectorsCLONTECH LAB INC·Filed 1997·Granted Nov 23, 1999·83 cites·22 claims
- 0282US8309550B2Kinase inhibitors and their use as pharmaceutical agentsLUO YING·Filed 2011·Granted Nov 13, 2012·9 cites·9 claims
- 0382US6391582B2Shuttle vectorsRIGEL PHARMACEUTICLAS INC·Filed 1998·Granted May 21, 2002·66 cites·3 claims
- 0481US7968781B1Resilient device for a drum pedalK H S MUSICAL INSTR CO LTD·Filed 2009·Granted Jun 28, 2011·10 cites·6 claims
- 0579US8026434B2Musical instrument pedalK H S MUSICAL INSTR CO LTD·Filed 2009·Granted Sep 27, 2011·10 cites·7 claims
- 0679US6887675B1Tankyrase H, compositions involved in the cell cycle and methods of useRIGEL PHARMACEUTICALS INC·Filed 2001·Granted May 3, 2005·7 cites·10 claims
- 0778US6645766B2Shuttle vectorsRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Nov 11, 2003·6 cites·4 claims
- 0874US7122630B1SYK-UBP polypeptides and methods of making and isolating sameRIGEL PHARMACEUTICALS INC·Filed 2000·Granted Oct 17, 2006·3 cites·4 claims
- 0973US7265214B2Germinal center kinase proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2001·Granted Sep 4, 2007·2 cites·15 claims
- 1072US6280937B1Shuttle vectorsRIGEL PHARMACEUTICALS INC·Filed 1998·Granted Aug 28, 2001·34 cites·10 claims
- 1168US6569658B1Germinal center kinase cell cycle proteinsRIGEL PHARMACEUTICALS INC·Filed 2000·Granted May 27, 2003·1 cites·16 claims
- 1266US6114111AMammalian protein interaction cloning systemRIGEL PHARMACEUTICALS INC·Filed 1998·Granted Sep 5, 2000·30 cites·41 claims
- 1365US6660511B1Methods of screening for modulation of cell cycleRIGEL PHARMACEUTICALS INC·Filed 2000·Granted Dec 9, 2003·5 cites·11 claims
- 1465US6316223B1Mammalian protein interaction cloning systemRIGEL PHARMACEUTICALS INC·Filed 1999·Granted Nov 13, 2001·29 cites·11 claims
- 1564US7488805B2Apoptosis proteinsRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Feb 10, 2009·0 cites·3 claims
- 1662US2024277682A1Pharmaceutical hydronidone formulations for diseasesGYRE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1761US7989688B2Pedal for musical instrumentsK H S MUSICAL INSTR CO LTD·Filed 2009·Granted Aug 2, 2011·4 cites·11 claims
- 1861US2008108098A1Novel germinal kinase proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1960US7485621B2Tumor tag and the use thereofSHANGHAI GENOMICS INC·Filed 2002·Granted Feb 3, 2009·1 cites·10 claims
- 2059US7001732B2RIP3 associated cell cycle proteinRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Feb 21, 2006·0 cites·5 claims
- 2157US2024261271A1Application of hydronidone in preparation of drug for treating or preventing chronic hepatitis b with liver fibrosisBEIJING CONTINENT PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2255US7423118B1IAPS associated cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2000·Granted Sep 9, 2008·0 cites·5 claims
- 2355US7420045B1IAPs associated cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2000·Granted Sep 2, 2008·0 cites·9 claims
- 2454US2006228761A1Novel RIP3 associated cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2553US7384761B2Methods of identifying an agent capable of interfering with Rad9 dephosphorylationRIGEL PHARMACEUTICALS INC·Filed 2001·Granted Jun 10, 2008·0 cites·9 claims
- 2652US6617102B1Tankyrase H, compositions involved in the cell cycle and methods of useRIGEL PHARMACEUTICALS INC·Filed 2000·Granted Sep 9, 2003·0 cites·4 claims
- 2750US9663451B2Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2014·Granted May 30, 2017·0 cites·8 claims
- 2850US2024301069A1Anti-PD-L1 Antibody and UsethereofGUANGDONG FAPON BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2949US9573891B2Complexes of agomelatine and sulphonic acids, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2014·Granted Feb 21, 2017·0 cites·14 claims
- 3049US7300780B2Germinal center kinase proteins, compositions, and methods of useRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Nov 27, 2007·0 cites·2 claims
- 3148US2011110649A1Adaptive video key frame selectionTHOMSON LICENSING·Filed 2008·Application pending·0 cites
- 3248US2005074825A1Tankyrase H, compositions involved in the cell cycle and methods of useFiled 2003·Application pending·0 cites
- 3347US7462704B2Tumor marker and its useSHANGHAI GENOMICS INC·Filed 2003·Granted Dec 9, 2008·0 cites·5 claims
- 3446US2023331840A1Cd22 antibody and application thereofFAPON BIOTHERAPY INC·Filed 2021·Application pending·0 cites
- 3545US2023068020A1Macrolide compound and its use of treatment chronic respiratory diseaseBEIJING CONTINENT PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3643US6709839B1SYK-UBP proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 1999·Granted Mar 23, 2004·3 cites·11 claims
- 3742US9601311B2Laser SDE effect compensation by adaptive tuningHERMES MICROVISION INC·Filed 2016·Granted Mar 21, 2017·0 cites·17 claims
- 3841US6696263B1PCNA associated cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 1999·Granted Feb 24, 2004·4 cites·12 claims
- 3941US6428980B1Nucleic acids encoding RIP3 associated cell cycle proteinsRIGEL PHARMACEUTICALS INC·Filed 1999·Granted Aug 6, 2002·2 cites·19 claims
- 4037US6589725B1Tankyrase H, compositions involved in the cell cycle and methods of useRIGEL PHARMACEUTICALS INC·Filed 1999·Granted Jul 8, 2003·3 cites·9 claims
- 4136US2014303163A1Use of kinase inhibitors in preventing and treating inflammatory disorderLUO YING·Filed 2011·Application pending·0 cites
- 4236US2015238614A1Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing itSERVIER LAB·Filed 2013·Application pending·0 cites
- 4335US6737232B1IAPs associated cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 1999·Granted May 18, 2004·2 cites·18 claims
- 4435US6562591B1Germinal center kinase cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 1999·Granted May 13, 2003·1 cites·23 claims
- 4534US6387658B1PCNA-associated cell cycle proteins, compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 1999·Granted May 14, 2002·1 cites·13 claims
- 4631US6623980B1Exo1 and Exo2, exocytotic proteinsRIGEL PHARMACEUTICALS INC·Filed 1999·Granted Sep 23, 2003·0 cites·12 claims
- 4729US7223850B1Apoptosis proteinsRIGEL PHARMACEUTICALS INC·Filed 1999·Granted May 29, 2007·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Ying Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →